Epizyme, Inc.·4

Feb 9, 5:58 PM ET

Epizyme, Inc. 4

4 · Epizyme, Inc. · Filed Feb 9, 2017

Insider Transaction Report

Form 4
Period: 2017-02-08
Copeland Robert A
EVP and CSO10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-08+97,65997,659 total
    Exercise: $12.45Exp: 2027-02-07Common Stock (97,659 underlying)
Footnotes (1)
  • [F1]This option was granted on February 8, 2017 pursuant to the Company's 2013 Stock Incentive Plan with respect to 97,659 shares of Common Stock, with 25% vesting on February 8, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION